{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:59:08Z","timestamp":1769569148638,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Priapism is defined as erection that lasts for more than 4\u00a0h without sexual stimulation. There are various causes of priapism, but there are no reports of sildenafil-induced priapism in dogs. In human medicine, there were no pre-marketing reports of priapism caused by sildenafil, but post-marketing surveillance has shown that it is rare. In cases of pulmonary hypertension in dogs, sildenafil is the first-line drug of choice for symptomatic relief.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>An 11-year-old neutered male Maltese dog that presented with tachypnea and cough was diagnosed with myxomatous mitral valve disease, American College of Veterinary Internal Medicine (ACVIM) stage C, and was treated medically. Eighteen months after the diagnosis, severe pulmonary hypertension occurred due to left heart disease. At 20 months postdiagnosis, pleural effusion occurred, and sildenafil (2\u00a0mg\/kg twice daily) was added to the existing treatment. Two weeks later, the dyspnea recurred, confirming pleural fluid recurrence, and sildenafil was increased to 2\u00a0mg\/kg thrice daily. One day later, the patient developed persistent erections and penile pain. Penile amputation and urethrostomy were recommended but were refused; therefore, analgesia and palliative care were provided. The patient died of acute dyspnea 22 months after the first presentation, with no specific priapism recurrence at the time of death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>To the best of our knowledge, this is the first report of sildenafil-induced priapism in a dog with pulmonary hypertension.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-024-04205-6","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T04:02:07Z","timestamp":1723089727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sildenafil-induced priapism in a dog : an unusual case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Hyo-Seung","family":"Nam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-In","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"4205_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ucl.2007.08.006","volume":"34","author":"AL Burnett","year":"2007","unstructured":"Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. Urol Clin North Am. 2007;34:631\u201342.","journal-title":"Urol Clin North Am"},{"key":"4205_CR2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/vetsci9100518","volume":"9","author":"FA Roux","year":"2022","unstructured":"Roux FA, Le Breuil F, Branchereau J, Deschamps JY. Stuttering priapism in a dog\u2014first report. Vet Sci. 2022;9:518.","journal-title":"Vet Sci"},{"key":"4205_CR3","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1111\/rda.12167","volume":"48","author":"R Payan-Carreira","year":"2013","unstructured":"Payan-Carreira R, Cola\u00e7o B, Rocha C, Albuquerque C, Luis M, Abreu H, et al. Priapism associated with lumbar stenosis in a dog. Reprod Domest Anim. 2013;48:e58\u201364.","journal-title":"Reprod Domest Anim"},{"key":"4205_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.tcam.2008.11.001","volume":"24","author":"JA Lavely","year":"2009","unstructured":"Lavely JA. Priapism in dogs. Top Companion Anim Med. 2009;24:49\u201354.","journal-title":"Top Companion Anim Med"},{"key":"4205_CR5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S0090-4295(99)00610-X","volume":"55","author":"RL Sur","year":"2000","unstructured":"Sur RL, Kane CJ. Sildenafil citrate-associated priapism. Urology. 2000;55:950.","journal-title":"Urology"},{"key":"4205_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/15563650701664483","volume":"45","author":"BK Wills","year":"2007","unstructured":"Wills BK, Albinson C, Wahl M, Clifton J. Sildenafil citrate ingestion and prolonged priapism and tachycardia in a pediatric patient. Clin Toxicol (Phila). 2007;45:798\u2013800.","journal-title":"Clin Toxicol (Phila)"},{"key":"4205_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","volume":"7","author":"GA Broderick","year":"2010","unstructured":"Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476\u2013500.","journal-title":"J Sex Med"},{"key":"4205_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0090-4295(00)00649-X","volume":"56","author":"SG Moreira Jr","year":"2000","unstructured":"Moreira SG Jr, Brannigan RE, Spitz A, Orejuela FJ, Lipshultz LI, Kim ED. Side-effect profile of sildenafil citrate (Viagra) in clinical practice. Urology. 2000;56:474\u20136.","journal-title":"Urology"},{"key":"4205_CR9","volume-title":"AHFS drug information 2018","author":"G McEvoy","year":"2018","unstructured":"McEvoy G, Snow E, American Society of Health System Pharmacists. AHFS drug information 2018. In: Bethesda, MD: American Society of Health System Pharmacists United States; 2018."},{"key":"4205_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jvim.15725","volume":"34","author":"C Reinero","year":"2020","unstructured":"Reinero C, Visser LC, Kellihan HB, Masseau I, Rozanski E, Clercx C, et al. ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. J Vet Intern Med. 2020;34:549\u201373.","journal-title":"J Vet Intern Med"},{"key":"4205_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Keene","year":"2019","unstructured":"Keene BW, Atkins CE, Bonagura JD, Fox PR, H\u00e4ggstr\u00f6m J, Fuentes VL, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127\u201340.","journal-title":"J Vet Intern Med"},{"key":"4205_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cvsm.2022.01.010","volume":"52","author":"SG Gordon","year":"2022","unstructured":"Gordon SG, Saunders AB, Wesselowski SR. Asymptomatic canine degenerative valve disease: diagnosis and current and future therapies. Vet Clin North Am Small Anim Pract. 2022;52:819\u201340.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"4205_CR13","doi-asserted-by":"crossref","unstructured":"Harmon WJ, Nehra A, Priapism. Diagnosis and management. Mayo Clin Proc. 1997;72:350-5.","DOI":"10.4065\/72.4.350"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-024-04205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-024-04205-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-024-04205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T12:03:36Z","timestamp":1732622616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-024-04205-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1186\/s12917-024-04205-6","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}